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Pure isocitrate dehydrogenase from pig liver cytoplasm catalyses the reduction of oxaloacetate by NADPH at a 
rate comparable with that observed for the usual substrates. The products are NADP and D-malate, the ‘unatural’ 
isomer. High concentrations of magnesium (25 mM) are necessary for maximal activity, and the reaction is not ap- 
preciably reversible. These results are discussed in connection with the inhibition of the enzyme by mixtures of 
glyoxylate and oxaloacetate. The reduction is not thought to be of physiological importance. 
1. Introduction 
A number of workers have studied the inhibition 
of isocitrate dehydrogenases from a variety of sources 
by mixtures of glyoxylate and oxaloacetate [l-3] . 
During the course of fluorimetric studies of this phe- 
nomenon it became apparent that oxaloacetate is a 
substrate for highly purified pig liver cytoplasmic iso- 
citrate dehydrogenase. This enzyme was recently ob- 
tained by us in a pure form [4] and satisfies all the 
usual criteria for homogeneity. 
2. Methods 
Tritiated Lmalic acid was prepared by the action 
of fumarase (0.2 mg) on 2 millimoles of sodium malate 
dissolved in 2 ml of tritiated water (100 mCi/ml) at 
pH 7.4 overnight. Excess tritium was removed by freeze 
drying, then 2 ml of 2 N HCl was added to destroy 
fumarase activity. Sodium was removed by passage 
through a column of sulphonated polystyrene (‘Zeo- 
Karb’ 225) in the hydrogen form, and HCl by rotary 
evaporation. No attempt was made to remove the 20% 
unlabelled fumarate present in the product. 
14CQxaloacetate was generated in the spectropho- 
tometer cuvette from 0.5 mM oxaloacetate and 0.5 mM 
14C-aspartate using 1 mg of glutamate/oxaloacetic trans- 
aminase in 2 ml of 50 mM pyridine acetate buffer pH 
6.0 containing 25 mM MgCl,. After 5 min the reduction 
of the oxaloacetic acid was started by the addition of 
NADPH to 0.6 mM final concentration and 0.1 mg 
pure isocitrate dehydrogenase, and the reaction fol- 
lowed to completion in the spectrophotometer. Ap- 
proximately 4 /.tCi of 14C-D-malate were obtained in 
this manner from 10 @i of aspartate. Excess aspar- 
tate was removed by passage through a column of 
‘Zeo-Karb’ 225 in the hydrogen form and the non- 
retarded material was mixed with 3H-L-malic acid to 
give a tritium carbon ratio suitable for double label 
counting. This mixture was chromatographed on a 
10 X 1 cm column of ‘Permutit’ De-acidite FFIP 
(strong base resin) in 0.5 M trimethylammonium bi- 
carbonate buffer, pH 8, and 3 ml fractions collected. 
Assay systems were as follows: 
1) Isocitrate oxidation: 1 mM &sodium isocitrate, 
1 mM MgC12 and 250 I.~M NADP in 50 mM triethanol- 
ammonium chloride, pH 8.1 at 25”. 
2) Oxaloacetate reduction: 1 mM oxaloacetic acid, 
25 mM MgCl2 and 125 PM NADPH in either 50 mM 
pyridine acetate or 100 mM sodium phosphate, pH 
6.0 at 25”. 
3) D-malate oxidation: 33 mM D-malic acid, 5 mM 
MgCl, and 25Ow NADP in 0.2 M hydrazine chloride 
pH 9.0 at 25”. (Semicarbazide inhibits isocitrate de- 
hydrogenase, so hydrazine, which is non inhibitory, 
was used both as buffer and as a trap for oxaloace- 
tate .) 
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3. Results 
In the assay systems described pure isocitrate de- 
hydrogenase has a specific activity of 46 international 
units per mg protein for isocitrate oxidation, and 9 
international units per mg for oxaloacetate reduction. 
The pH optimum actually lies somewhat below 6.0 
for oxaloacetate reduction, but the instability of both 
enzyme and substrates at this pH makes it unsuitable 
for general use. The reaction was scarcely reversible 
under the conditions tested, the rate of D-malate oxi- 
dation was only 0.1% of the rate of isocitrate oxida- 
tion in the same system. D-malate oxidation is 90% 
inhibited by 3 mM glyoxylate. 
The feeble rate with D-malate makes it desirable to 
have a positive identification of the products of oxalo- 
acetate reduction. If oxaloacetate reduction is allowed 
to proceed to completion all of the NADPH consumed 
is subsequently regenerated on addition of excess iso- 
citrate, so one product must almost certainly be NADP. 
By following oxaloacetate disappearance at 283 nm 
(the isosbestic point for the NADP/NADPH pair) and 
NADPH oxidation at 340 nm it is easy to establish that 
there is a one to one correspondence between NADPH 
oxidation and oxaloacetate reduction after allowing 
for a slight non-enzymic blank rate. As can be seen 
from fig. 1, the reaction product co-chromatographs 
with genuine malic acid. The reaction product must 
be D-malate as it is not a substrate for malate dehy- 
drogenase. This is easily shown by adding NAD, hydra- 
zine hydrate, and malate dehydrogenase to the normal 
assay cocktail after oxaloacetate reduction is complete. 
No NADH is produced although only 5 nmoles of ge- 
nuine malate are needed to produce a detectable rise 
in absorbance. 
In the absence of CO, 2-oxoglutarate is a potent 
competitive inhibitor of oxaloacetate reduction. Suc- 
cinate and fumarate, but not maleate are also somewhat 
inhibitory. Oxaloacetate samples themselves contain 
traces of an inhibitor (perhaps a condensation product) 
which is rapidly destroyed in the presence of MgCl,. 
In consequence an accelerating initial rate is observed 
unless the assay cocktail is incubated for three min 
before addition of enzyme. 
The optimal magnesium concentration for oxalo- 
acetate reduction is some 25 times higher than the op- 
timal concentration for isocitrate oxidation or 2-0x0- 
glutarate reductive carboxylation. We suspect that the 
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Fig. 1. Chromatography of oxaloacetate reduction products 
on a strong base ion exchange resin. 
(The elution positions of aspartic acid and oxaloacetate 
acid were determined in separate xperiments. Oxaloacetic 
acid is very strongly retarded in this system and is not shown. 
The minor peak is probably pyruvate.) 
true substrate may be the magnesium complex of the 
enol form of oxaloacetate. Formation of such a com- 
plex may be observed if the difference spectrum of 
oxaloacetate + MgCl, is observed relative to an oxalo- 
acetate blank in the region of 290 nm at pH values 
around neutrality. In alkali this difference spectrum 
is greatly intensified. A similar result is obtained with 
phenylpyruvate at 320 nm, which suggests that these 
complexes involve a five membered ring chelate rather 
than the six membered structure which is only pos- 
sible with oxaloacetate. The high dissociation constant 
(25 mM) which may be calculated from these spectra 
agrees well with the high magnesium requirement for 
the enzymic reaction. lsocitrate dehydrogenase does 
not appear to decarboxylate oxaloacetate to any ex- 
tent. This again might be expected if the enol form of 
oxaloacetate were the true substrate. 
Oxaloacetate reduction is progressively inhibited 
by 0.1 mM glyoxylate. This inhibition has an absolute 
requirement for NADP, as is illustrated by the results in 
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table 1. NADPH will not replace NADP, and in systems 
containing no NADP no inhibition is observed until a 
small amount of NADPH has been oxidised by the 
oxaloacetate present. 
quent time course of inhibition were the same in all 
cases. 
It has been suggested [2] that the inhibition due to 
glyoxylate plus oxaloacetate results from their con- 
densation to form the substrate analogue, oxalomalate. 
It is also possible that this condensation is catalysed 
by the enzyme itself [5]. Isocitrate dehydrogenase is 
clearly able to bind oxaloacetate to the active site, and 
a subsequent condensation to form oxalomalate would 
be closely analogous to the normal fixation of CO2 
during the reductive carboxylation of 2-oxoglutarate. 
It is clear from the experiments in which only glyoxyl- 
ate and oxaloacetate were preincubated together be- 
fore addition of the enzyme that the concentration of 
inhibitor does not increase with time in the absence of 
the enzyme, since both the initial rate and the subse- 
There is a second possible explanation. Oxalo- 
acetate is not stable in the reaction buffer, and at 283 
nm a slow fall in absorbance results from a magnesium 
dependent non-enzymic decarboxylation. Oxalomalate 
[2] is reported to be even more unstable than oxalo- 
acetate, and undergoes an extremely rapid decarboxyl- 
ation in the presence of magnesium. When no enzyme 
is present the addition of glyoxylate to solutions of 
oxaloacetate in the assay buffer accelerates the fall in 
absorbance at 283 run. The decarboxylation rate of 
1 mM oxaloacetate is doubled by 5 mM glyoxylate in 
the presence of 25 mM MgC&. 
The decomposition product of oxalomalate has not 
been positively identified. There are a number of pos- 
sible products, however the end result is the same in 
all cases - a steady state level of oxalomalate is estab- 
Table 1 
Inhibition experiments in 100 mM sodium phosphate pH 6.0 containing 25 mM MgCl2 at 25’. The following reagent concentra- 
tions were employed: 50 PM NADP, 125 gM NADPH, 1.0 mM oxaloacetate, 0.1 mM glyoxylate. Unless otherwise stated the pre- 
incubations were of 3 min duration. 0.005 mg enzyme was added per assay and the total reaction volume was 2 ml. 
Mixture preincubated in 
cuvette 
Oxaloacetate, NADPH, 
Additions at start of 
reaction 
Enzyme 
Initial rate and 
time for 50% inhibition 
40 nmoles/min 
no inhibition 
Oxaloacetate, NADPH, 
NADP 
Oxaloacetate, NADPH, 
NADP, glyoxylate 
Oxaloacetate, NADPH, 
glyoxylate 
Enzyme, oxaloacetate, 
NADP, glyoxylate 
Enzyme, oxaloacetate, 
glyoxylate 
Oxaloacetate and 
glyoxylate for times 
ranging from 3 to 30 
min 
Enzyme 
Enzyme 
Enzyme 
NADPH 
NADPH 
NADP, NADPH, and 
Enzyme 
40 mnoles/min 
no inhibition 
40 nmoles/min 
20 set 
40 nmoles/min 
60 set approximately* 
12 nmoles/min 
20 set 
40 nmoles/min 
60 set approximately* 
40 nmoles/min 
20 set approximately 
* in these cases the 
inhibition is not truly 
first order. 
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fast 
Oxaloacetate + Mg2’ 7 
slow 
(Mg oxaloacetate) - 
/ 
pyruvate + Mg2’ 
slow 
J 
(Mg oxalomalate) 
lished in a few set after adding glyoxylate, and this used in this work. We are indebted to Dr. A.R.Hunter 
extremely low level thereafter changes only slowly for his assistance with the double label experiments. 
with time as the oxaloacetate and glyoxylate are gradu- J.A.I. thanks the Science Research Council for a re- 
ally depleted. search studentship. 
It is not possible to distinguish between these two 
cases at present, and indeed this will be extremely dif- 
ficult. It is also unclear why oxalomalate should inhibit 
the enzyme and this problem is now under active study. 
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